Mannitol Injection/ Infusion
-
SpecificationCP;BP;USP;IP;Customized
-
dosage20.0%
-
Volume250ml
-
Dosage FormsLVP (Large Volume Parenteral) Injections
-
Packing MaterialsGlass bottle;Polypropylene (PP) bottle
-
Composition
Each 1ml of solution contains 20% w/v of Mannitol.
Indications:
For Intravenous Injection
Mannitol Injection, USP is indicated for the following therapeutic uses:
• The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established.
• The reduction of intracranial pressure and treatment of cerebral edema by reducing brain mass.
• The reduction of elevated intraocular pressure when it cannot be lowered by other means.
• The promotion of urinary excretion of toxic substances.
For Urologic Irrigation
Mannitol solution, 2.5% is indicated as an irrigation solution in transurethral prostatic resection or other transurethral surgical procedures.
Storage:
Store in an airtight container, protect from light.